These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16819504)

  • 1. Evidence that MIG-6 is a tumor-suppressor gene.
    Zhang YW; Staal B; Su Y; Swiatek P; Zhao P; Cao B; Resau J; Sigler R; Bronson R; Vande Woude GF
    Oncogene; 2007 Jan; 26(2):269-76. PubMed ID: 16819504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancer.
    Lin CI; Du J; Shen WT; Whang EE; Donner DB; Griff N; He F; Moore FD; Clark OH; Ruan DT
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E554-65. PubMed ID: 21190978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitogen-inducible gene-6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinoma.
    Reschke M; Ferby I; Stepniak E; Seitzer N; Horst D; Wagner EF; Ullrich A
    Hepatology; 2010 Apr; 51(4):1383-90. PubMed ID: 20044804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low expression of Mig-6 is associated with poor survival outcome in NSCLC and inhibits cell apoptosis via ERK-mediated upregulation of Bcl-2.
    Li Z; Qu L; Zhong H; Xu K; Qiu X; Wang E
    Oncol Rep; 2014 Apr; 31(4):1707-14. PubMed ID: 24573418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma.
    Kang DH; Jung SS; Yeo MK; Lee DH; Yoo G; Cho SY; Oh IJ; Kim JO; Park HS; Chung C; Lee JE
    BMC Cancer; 2020 Jun; 20(1):571. PubMed ID: 32552717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of Mig-6 in nonsmall-cell lung cancer is associated with EGFR signaling.
    Li Z; Dong Q; Wang Y; Qu L; Qiu X; Wang E
    Mol Carcinog; 2012 Jul; 51(7):522-34. PubMed ID: 21739478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mig-6 overcomes gefitinib resistance by inhibiting EGFR/ERK pathway in non-small cell lung cancer cell lines.
    Li ZX; Qu LY; Wen H; Zhong HS; Xu K; Qiu XS; Wang EH
    Int J Clin Exp Pathol; 2014; 7(10):7304-11. PubMed ID: 25400829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mig-6 deficiency cooperates with oncogenic Kras to promote mouse lung tumorigenesis.
    Liu J; Cho SN; Wu SP; Jin N; Moghaddam SJ; Gilbert JL; Wistuba I; DeMayo FJ
    Lung Cancer; 2017 Oct; 112():47-56. PubMed ID: 29191600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mig-6 is required for appropriate lung development and to ensure normal adult lung homeostasis.
    Jin N; Cho SN; Raso MG; Wistuba I; Smith Y; Yang Y; Kurie JM; Yen R; Evans CM; Ludwig T; Jeong JW; DeMayo FJ
    Development; 2009 Oct; 136(19):3347-56. PubMed ID: 19710174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma.
    Maity TK; Venugopalan A; Linnoila I; Cultraro CM; Giannakou A; Nemati R; Zhang X; Webster JD; Ritt D; Ghosal S; Hoschuetzky H; Simpson RM; Biswas R; Politi K; Morrison DK; Varmus HE; Guha U
    Cancer Discov; 2015 May; 5(5):534-49. PubMed ID: 25735773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid-specific knockout of the tumor suppressor mitogen-inducible gene 6 activates epidermal growth factor receptor signaling pathways and suppresses nuclear factor-κB activity.
    Lin CI; Barletta JA; Nehs MA; Morris ZS; Donner DB; Whang EE; Jeong JW; Kimura S; Moore FD; Ruan DT
    Surgery; 2011 Dec; 150(6):1295-302. PubMed ID: 22136853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas.
    Olivero M; Rizzo M; Madeddu R; Casadio C; Pennacchietti S; Nicotra MR; Prat M; Maggi G; Arena N; Natali PG; Comoglio PM; Di Renzo MF
    Br J Cancer; 1996 Dec; 74(12):1862-8. PubMed ID: 8980383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of Met/hepatocyte growth factor receptor in subtypes of non-small cell lung cancers.
    Tsao MS; Liu N; Chen JR; Pappas J; Ho J; To C; Viallet J; Park M; Zhu H
    Lung Cancer; 1998 Apr; 20(1):1-16. PubMed ID: 9699182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
    Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T
    J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human lung cancer cell line producing hepatocyte growth factor/scatter factor.
    Yoshinaga Y; Fujita S; Gotoh M; Nakamura T; Kikuchi M; Hirohashi S
    Jpn J Cancer Res; 1992 Dec; 83(12):1257-61. PubMed ID: 1336496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine induces resistance to epidermal growth factor receptor tyrosine kinase inhibitor by α1 nicotinic acetylcholine receptor-mediated activation in PC9 cells.
    Wang S; Takayama K; Tanaka K; Takeshita M; Nakagaki N; Ijichi K; Li H; Nakanishi Y
    J Thorac Oncol; 2013 Jun; 8(6):719-25. PubMed ID: 23625155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mig-6, signal transduction, stress response and cancer.
    Zhang YW; Vande Woude GF
    Cell Cycle; 2007 Mar; 6(5):507-13. PubMed ID: 17351343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
    Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
    Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of epidermal growth factor receptor (EGFR) and downstream-activated peptides in surgically excised non-small-cell lung cancer (NSCLC).
    Mukohara T; Kudoh S; Yamauchi S; Kimura T; Yoshimura N; Kanazawa H; Hirata K; Wanibuchi H; Fukushima S; Inoue K; Yoshikawa J
    Lung Cancer; 2003 Aug; 41(2):123-30. PubMed ID: 12871775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulatory effects of hepatocyte growth factor on normal and neoplastic human bronchial epithelial cells.
    Singh-Kaw P; Zarnegar R; Siegfried JM
    Am J Physiol; 1995 Jun; 268(6 Pt 1):L1012-20. PubMed ID: 7611423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.